Daniel Johnsson
Direktor/Vorstandsmitglied bei TURA GROUP AB
Vermögen: 5 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Nicholas Waters | M | 62 | 11 Jahre | |
Gunnar Olof Olsson | M | 71 | 7 Jahre | |
Erik Viktor Siewertz | M | 53 | 11 Jahre | |
Hans-Peter Albert Ostler | M | 53 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | - |
Jan Anders Vedin | M | 82 | 8 Jahre | |
Petra Carnbäck | F | 48 | - | |
Jonas Wimmerstedt | M | 54 | - | |
Catharina Gustafsson Wallich | F | 60 | 2 Jahre | |
Carola Elisabet Lemne | M | 66 | 5 Jahre | |
Sebastian Johansson | M | - |
Postery AB
Postery AB Specialty StoresRetail Trade Postery AB is a Swedish brand that offers a wide range of stylish posters and prints online. The private company is based in Gothenburg, Sweden. The Swedish company adds new designs every week, and their collection includes the latest trends in posters. Postery collaborates with talented artists like Marilyne Verschueren, also known as beamingdesign, who creates unique art prints that encourage people to appreciate the beauty of life. The company was founded by Sebastian Johansson, who has been the CEO since incorporation. | - |
Rein Piir | M | 66 | 8 Jahre | |
Hans Gustaf Jacobsson | M | 57 | - | |
Clas Sonesson | M | 63 | 11 Jahre | |
Kristina Hallström | F | - |
Nanoecho AB
| - |
Christer Nordstedt | M | 62 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | 2 Jahre |
Par Eriksson | M | 52 | - | |
Peter Olsson | M | 51 | - | |
Stefan Eriksson | M | 58 | 33 Jahre | |
Linda Persson | M | 46 |
Nanoecho AB
| - |
Hannes Wallin | M | 42 |
JHD Holding AB
| - |
Joakim Tedroff | M | 63 | 8 Jahre | |
Susanna Waters | M | 58 | - | |
Henrik Ljung | M | 66 |
Nanoecho AB
| - |
Veronica Wallin | F | 38 | 1 Jahre | |
Peder Svensson | M | 62 | 8 Jahre | |
Mats Almgren | M | 68 | 13 Jahre | |
Marianne Dicander Alexandersson | F | 65 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | - |
Johannes Swartling | M | 52 |
Nanoecho AB
| - |
Lennart Erik Jonas Sjögren | M | 58 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | - |
Inga Sarah Maria Fredriksson | M | 56 |
Nanoecho AB
| - |
Claes Tomas Post | M | 74 |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | - |
Anki Malmborg Hager | M | 59 |
Nanoecho AB
| - |
Mats Lindskog | M | - |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Maria Jalmelid | F | 45 | 5 Jahre | |
Richard Stuart Godfrey | M | 58 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 35 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel Johnsson
- Persönliches Netzwerk